Louisiana State Employees Retirement System’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$567K Hold
2,500
0.01% 1352
2026
Q1
$431K Hold
2,500
0.01% 1388
2025
Q4
$499K Sell
2,500
-100
-4% -$18.1K 0.01% 1364
2025
Q3
$407K Hold
2,600
0.01% 1400
2025
Q2
$394K Sell
2,600
-200
-7% -$26.7K 0.01% 1394
2025
Q1
$421K Hold
2,800
0.01% 1376
2024
Q4
$517K Sell
2,800
-100
-3% -$19.3K 0.01% 1330
2024
Q3
$571K Hold
2,900
0.01% 1312
2024
Q2
$599K Sell
2,900
-100
-3% -$22.7K 0.01% 1265
2024
Q1
$813K Sell
3,000
-100
-3% -$23.9K 0.02% 1126
2023
Q4
$733K Sell
3,100
-100
-3% -$19.7K 0.02% 1181
2023
Q3
$627K Hold
3,200
0.01% 1193
2023
Q2
$673K Sell
3,200
-100
-3% -$19.9K 0.01% 1175
2023
Q1
$666K Hold
3,300
0.02% 1100
2022
Q4
$719K Hold
3,300
0.02% 1022
2022
Q3
$649K Buy
3,300
+100
+3% +$21.6K 0.02% 1035
2022
Q2
$723K Hold
3,200
0.02% 1032
2022
Q1
$950K Hold
3,200
0.02% 915
2021
Q4
$1.21M Buy
3,200
+100
+3% +$38.9K 0.03% 786
2021
Q3
$1.28M Hold
3,100
0.03% 681
2021
Q2
$1.15M Sell
3,100
-9,800
-76% -$3.27M 0.03% 770
2021
Q1
$3.74M Buy
12,900
+500
+4% +$139K 0.1% 160
2020
Q4
$3.1M Hold
12,400
0.09% 183
2020
Q3
$2.81M Hold
12,400
0.13% 126
2020
Q2
$2.16M Buy
12,400
+600
+5% +$95.8K 0.13% 140
2020
Q1
$1.49M Hold
11,800
0.11% 184
2019
Q4
$1.8M Buy
11,800
+100
+0.9% +$13.8K 0.09% 220
2019
Q3
$1.55M Sell
11,700
-800
-6% -$107K 0.08% 256
2019
Q2
$1.69M Sell
12,500
-400
-3% -$54.3K 0.08% 246
2019
Q1
$1.87M Buy
12,900
+100
+0.8% +$13.1K 0.09% 203
2018
Q4
$1.45M Sell
12,800
-400
-3% -$50.1K 0.08% 250
2018
Q3
$1.78M Buy
13,200
+300
+2% +$37K 0.08% 268
2018
Q2
$1.45M Buy
12,900
+400
+3% +$43.2K 0.07% 340
2018
Q1
$1.33M Buy
12,500
+500
+4% +$53.9K 0.06% 382
2017
Q4
$1.31M Sell
12,000
-700
-6% -$76.2K 0.06% 394
2017
Q3
$1.37M Buy
12,700
+300
+2% +$30.8K 0.06% 352
2017
Q2
$1.25M Buy
12,400
+400
+3% +$36.8K 0.06% 377
2017
Q1
$1.08M Buy
12,000
+300
+3% +$25.5K 0.05% 454
2016
Q4
$891K Sell
11,700
-500
-4% -$38K 0.05% 571
2016
Q3
$1.02M Sell
12,200
-300
-2% -$25.1K 0.05% 473
2016
Q2
$1.03M Sell
12,500
-500
-4% -$41.2K 0.05% 457
2016
Q1
$987K Buy
13,000
+100
+0.8% +$7.4K 0.05% 489
2015
Q4
$1.04M Buy
12,900
+300
+2% +$21.6K 0.05% 464
2015
Q3
$800K Buy
12,600
+100
+0.8% +$7.18K 0.04% 642
2015
Q2
$879K Buy
12,500
+400
+3% +$29.6K 0.04% 635
2015
Q1
$959K Sell
12,100
-700
-5% -$51.6K 0.05% 582
2014
Q4
$815K Buy
12,800
+100
+0.8% +$6.27K 0.04% 722
2014
Q3
$759K Sell
12,700
-300
-2% -$17.2K 0.04% 735
2014
Q2
$696K Buy
13,000
+200
+2% +$11K 0.03% 845
2014
Q1
$772K Sell
12,800
-300
-2% -$17.5K 0.04% 742
2013
Q4
$695K Buy
+13,100
New +$658K 0.03% 827

Other funds holding CRL

Louisiana State Employees Retirement System's CRL Position: Q2 2026 in Review

Louisiana State Employees Retirement System held its Charles River Laboratories (CRL) position steady in Q2 2026 at 2,500 shares worth $567K. The position accounts for 0.01% of the portfolio, ranked #1352.

Louisiana State Employees Retirement System first reported a position in CRL in Q4 2013 and has held it in 51 quarters since. The position peaked at $3.74M in Q1 2021. 132 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • Louisiana State Employees Retirement System held 2,500 shares of Charles River Laboratories worth $567K as of Q2 2026.
  • Louisiana State Employees Retirement System left its Charles River Laboratories share count unchanged in Q2 2026.
  • Charles River Laboratories made up 0.01% of Louisiana State Employees Retirement System's portfolio in Q2 2026, its #1352 holding.
  • Louisiana State Employees Retirement System first reported a position in Charles River Laboratories in Q4 2013 and has held it in 51 quarters since.
  • Louisiana State Employees Retirement System's Charles River Laboratories position peaked at $3.74M in Q1 2021.
  • 132 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Louisiana State Employees Retirement System's 13F filing for Q2 2026, filed 20 Jul 2026.